申请人:Schering Corporation
公开号:EP1939213A1
公开(公告)日:2008-07-02
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
本发明公开了具有 HCV 蛋白酶抑制活性的新型化合物以及制备此类化合物的方法。在另一个实施方案中,本发明公开了包含此类化合物的药物组合物,以及使用此类化合物治疗与 HCV 蛋白酶相关疾病的方法。